| Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ A Gronchi, AB Miah, AP Dei Tos, N Abecassis, J Bajpai, S Bauer, ... Annals of Oncology 32 (11), 1348-1365, 2021 | 600 | 2021 |
| S100A4 and metastasis: a small actor playing many roles K Boye, GM Mælandsmo The American journal of pathology 176 (2), 528-535, 2010 | 520 | 2010 |
| Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, JY Blay, N Abecassis, J Bajpai, S Bauer, R Biagini, S Bielack, ... Annals of oncology 33 (1), 20-33, 2022 | 332 | 2022 |
| Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up SJ Strauss, AM Frezza, N Abecassis, J Bajpai, S Bauer, R Biagini, ... Annals of Oncology 32 (12), 1520-1536, 2021 | 240 | 2021 |
| Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer K Schee, K Boye, TW Abrahamsen, Ø Fodstad, K Flatmark BMC cancer 12, 1-8, 2012 | 211 | 2012 |
| B7‐H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer VA Ingebrigtsen, K Boye, C Tekle, JM Nesland, K Flatmark, Ø Fodstad International journal of cancer 131 (11), 2528-2536, 2012 | 130 | 2012 |
| Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network GD Demetri, CR Antonescu, B Bjerkehagen, JVMG Bovee, K Boye, ... Annals of Oncology 31 (11), 1506-1517, 2020 | 129 | 2020 |
| Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden P Peneder, AM Stütz, D Surdez, M Krumbholz, S Semper, M Chicard, ... Nature communications 12 (1), 3230, 2021 | 128 | 2021 |
| Expression of S100A4, E-cadherin, α-and β-catenin in breast cancer biopsies KB Pedersen, JM Nesland, Ø Fodstad, GM Maelandsmo British journal of cancer 87 (11), 1281-1286, 2002 | 121 | 2002 |
| Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts S Stacchiotti, AB Miah, AM Frezza, C Messiou, C Morosi, A Caraceni, ... ESMO open 6 (3), 100170, 2021 | 113 | 2021 |
| Nuclear localization of the metastasis‐related protein S100A4 correlates with tumour stage in colorectal cancer K Flatmark, KB Pedersen, JM Nesland, H Rasmussen, G Aamodt, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003 | 108 | 2003 |
| Noninvasive detection of ctDNA reveals intratumor heterogeneity and is associated with tumor burden in gastrointestinal stromal tumor HM Namløs, K Boye, SJ Mishkin, T Barøy, S Lorenz, B Bjerkehagen, ... Molecular cancer therapeutics 17 (11), 2473-2480, 2018 | 103 | 2018 |
| Activation of NF‐κB by extracellular S100A4: Analysis of signal transduction mechanisms and identification of target genes K Boye, I Grotterød, HC Aasheim, E Hovig, GM Mælandsmo International journal of cancer 123 (6), 1301-1310, 2008 | 93 | 2008 |
| B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome VA Ingebrigtsen, K Boye, JM Nesland, A Nesbakken, K Flatmark, ... BMC cancer 14, 1-9, 2014 | 91 | 2014 |
| Activity of pazopanib and trabectedin in advanced alveolar soft part sarcoma S Stacchiotti, O Mir, A Le Cesne, B Vincenzi, A Fedenko, RG Maki, ... The oncologist 23 (1), 62-70, 2018 | 81 | 2018 |
| Molecular modelling and simulations in cancer research R Friedman, K Boye, K Flatmark Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1836 (1), 1-14, 2013 | 76 | 2013 |
| Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma: a multi-institutional case series AM Frezza, RL Jones, SL Vullo, N Asano, F Lucibello, E Ben-Ami, ... JAMA oncology 4 (9), e180219-e180219, 2018 | 75 | 2018 |
| High expression of the cysteine proteinase legumain in colorectal cancer–Implications for therapeutic targeting MH Haugen, K Boye, JM Nesland, SJ Pettersen, EV Egeland, T Tamhane, ... European journal of cancer 51 (1), 9-17, 2015 | 72 | 2015 |
| Osteopontin—An important downstream effector of S100A4‐mediated invasion and metastasis G Berge, S Pettersen, I Grotterød, IJ Bettum, K Boye, GM Mælandsmo International journal of cancer 129 (4), 780-790, 2011 | 70 | 2011 |
| Definition and clinical significance of tumour rupture in gastrointestinal stromal tumours of the small intestine T Hølmebakk, B Bjerkehagen, K Boye, Ø Bruland, S Stoldt, K Sundby Hall Journal of British Surgery 103 (6), 684-691, 2016 | 67 | 2016 |
